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Abstract: The loss of the red blood cells (RBCs) deformability is related with many human diseases,
such as malaria, hereditary spherocytosis, sickle cell disease, or renal diseases. Hence, during the
last years, a variety of technologies have been proposed to gain insights into the factors affecting the
RBCs deformability and their possible direct association with several blood pathologies. In this work,
we present a simple microfluidic tool that provides the assessment of motions and deformations of
RBCs of end-stage kidney disease (ESKD) patients, under a well-controlled microenvironment. All of
the flow studies were performed within a hyperbolic converging microchannels where single-cell
deformability was assessed under a controlled homogeneous extensional flow field. By using a
passive microfluidic device, RBCs passing through a hyperbolic-shaped contraction were measured
by a high-speed video microscopy system, and the velocities and deformability ratios (DR) calculated.
Blood samples from 27 individuals, including seven healthy controls and 20 having ESKD with or
without diabetes, were analysed. The obtained data indicates that the proposed device is able to
detect changes in DR of the RBCs, allowing for distinguishing the samples from the healthy controls
and the patients. Overall, the deformability of ESKD patients with and without diabetes type II
is lower in comparison with the RBCs from the healthy controls, with this difference being more
evident for the group of ESKD patients with diabetes. RBCs from ESKD patients without diabetes
elongate on average 8% less, within the hyperbolic contraction, as compared to healthy controls;
whereas, RBCs from ESKD patients with diabetes elongate on average 14% less than the healthy
controls. The proposed strategy can be easily transformed into a simple and inexpensive diagnostic
microfluidic system to assess blood cells deformability due to the huge progress in image processing
and high-speed microvisualization technology.
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1. Introduction
Blood is a complex and an extremely information-rich fluid that can be used to diagnose different
kinds of blood diseases with multiple biophysical techniques and tools [1,2]. Under normal healthy
conditions, the red blood cells (RBCs) comprise about 42% in adult females and 47% in adult males
of the total blood volume [3]. As RBCs are the most abundant cells in blood, their deformable
properties strongly influence the blood rheological properties, particularly in microvessels with
complex geometries and diameters of less than 300 µm [4]. Several research works have found that
complex microgeometries, such as contractions [5,6] and bifurcations [2,7–9], promote the presence of
strong shear and extensional flows that elongate the RBCs without reaching the rupture.
Ever since the RBCs deformability became a potential biomarker for blood diseases, such as
malaria [10,11], sickle cell disease [1,12], and diabetes [13–15], several techniques have been developed
to measure the biomechanical properties of the RBCs. Additionally, there have been several reviews
that discuss different kind of experimental methods to measure the RBC deformability [1,2,16–18].
The available methods can be divided in two main kinds, i.e., the high-throughput methods that
measure high concentrations or diluted suspensions of RBCs, and the single-cell techniques. The
most popular high-throughput methods, which include the conventional rotational viscometer [19–21],
ektacytometer [9,14] and micro-pore filtration assay [9], have been used to measure the blood viscosity
and other rheological properties, but they are generally expensive, labor intensive, and do not provide
a direct and detailed source of information on the mechanical properties of the RBCs. A recent study
that was performed by Sosa et al. [9] has shown that the results from the micro-pore filtration and
ektacytometry were often in disagreement, and that neither of them represent the actual blood flow
conditions occurring in microvascular networks. Other methods, known as single-cell techniques,
which include the micropipette aspiration and optical tweezers, are also extremely popular for
measuring the mechanical properties of the RBC membrane [1,13]. However, these techniques also
have several drawbacks, such as a low-throughput, labor intensive, and static process. Additionally,
it is argued that these methods do not represent the actual RBC deformability that happens during
microcirculation [2].
The progress in microfabrication made fabricating microfluidic devices with the ability to
directly visualize, measure, and control the motion and deformation of RBCs flowing through
constricted [19,22–24] and bifurcated microchannels [7,9,24] possible. The distinctive advantage of
the microfluidic devices, such as the need of small sample’s volumes and their ability to reproduce
more realistic conditions of the microcirculation, have promoted a vast amount of studies on the cell
motion and deformability, mainly under the shear flow effect [3,6,16,20,25–27]. Some examples are
the deformability measurements that were performed under transient high shear stress in sudden
constriction channels, [16,28] and in microchannels with dimensions that were comparable to cell
size [2,16]. Besides the shear flow effect, the extensional flow and the combination of both can be
often found in the microcirculation system, such as in microstenosis and microvascular networks.
Hence, during the last decade, several extensional blood flow studies have been performed in cross
slot devices [29,30] and in microfluidic devices with hyperbolic channels [31–36]. Recent studies that
were performed in cross slot devices [37] and sudden constriction channels [26] have shown that cells
entrance location and angular orientation strongly affect the cells deformability. On the other hand,
extensional flows, where cells are deformed at almost constant strain rates, has been demonstrated to be
a microfluidic methodology that is capable of efficiently and accurately probing singe-cell deformability
with high throughputs [16,29].
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Additionally, the ability of hyperbolic-shaped contraction channels to generate constant strain-rates
makes them a promising strategy for measuring RBCs deformability under a well-controlled
microenvironment. Taking these advantage into account, the present study investigates the ability
of hyperbolic microfluidic channels to measure the deformation and cell motion of RBCs that were
obtained from healthy and diseased individuals (having end-stage kidney disease (ESKD), with or
without diabetes type II) and exploits the relevance of this flow technique to be used as a viable tool
suitable for detecting and diagnosing RBC related diseases.
Chronic kidney disease (CKD) is a pathological condition that results from a gradual, permanent
loss of kidney function over time, usually, months to years, which can lead to an end-stage kidney
disease (ESKD) [38]. This condition is associated with a decreased quality of life [39], increased
hospitalization [39,40], cardiovascular complications, such asangina, left ventricular hypertrophy
(LVH), and chronic heart failure, and increased mortality [41,42].
The remainder of this paper is organized, as follows: Section 2 comprises several subsections
to explain the experimental framework around blood samples, setups used to acquire the data,
and methods used to analyze it. Sections 3 and 4 presents and results and discussion, respectively.
2. Materials and Methods
2.1. Patients
In this study, a total of 20 ESKD patients under online hemodiafiltration (OL-HDF) that voluntary
accepted to participate in the study, have been tested. From those, eight additionally showed diabetic
nephropathy. Patients were excluded if they: (1) did not accept to participate in the study; (2) were
under 18 years old; (3) were cognitively impaired; (4) had a severe speech or hearing impairment;
(5) were in the dialysis program for less than three months; and, (6) presented malignancy, autoimmune,
inflammatory, or infectious diseases.
The control group included seven healthy volunteers presenting normal haematological and
biochemical values, with no history of renal or inflammatory diseases, and, as far as possible, age- and
gender-matched with ESKD patients. The controls did not receive any medication known to interfere
with the studied variables. Blood samples (using EDTA as anticoagulant) were drawn from the fasting
controls or before the second dialysis session of the week in ESKD patients.
All of the blood samples were obtained from dialysis patients at the hemodialysis clinic of
Gondomar, in Porto, Portugal. Informed consent was obtained from all the participants and this study
was approved by the clinic’s ethics review board.
2.2. Microfluidic Device, Experimental Setup and Parameters
The polydimethylsiloxane (PDMS) microfluidic devices that were evaluated in this work were
fabricated by using a conventional soft-lithographic technique [22]. To perform the deformability
assessment, hyperbolic converging microchannels were fabricated with 382 µm of length (Lc), as well
as maximum width of 400 µm (W1) and minimum width of 20 µm (W2) at the wide and narrow sizes,
respectively (cf. Figure 1). This particular geometry corresponds to a hyperbolic contraction with a
Hencky strain (εH) of ~3. Note that the εH can be defined as ln (W1/W2) [32]. The advantages of the use
of this hyperbolic geometry for RBCs screening have already been ascribed in previous studies [43,44].
The hyperbolic contraction geometry was chosen, mainly due to the strong extensional flow that was
generated in the middle of the microchannel, which is dominant over the shear flow. The cells by
passing through the hyperbolic contraction are submitted to a strong extensional flow, where the
velocity almost linearly increases, but the strain rate stays approximately constant. Note that the depth
was about 50 µm along the full length of the device.
Figure 1b also shows the main advantage of using hyperbolic converging microchannels. At the
entrance of these kinds of geometries, the RBCs tend to exhibit a linear increase of their velocities
and consequently the strain rates within the hyperbolic contractions are close to a constant. This
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flow phenomenon imposes a homogenous mechanical fluid behaviour to the RBCs and avoids some
possible motions (tumbling, twisting, and rolling rotations), often observed in abrupt contractions [26].
Hence, by using hyperbolic converging microchannels, most of the RBCs tend to elongate when they
flow through the contraction. It is worth mentioning that RBCs motions, such as tumbling, twisting,
and rolling rotations, were never observed during our experiments.
Figure 1. Microfluidic device fabricated in polydimethylsiloxane (PDMS) with a hyperbolic-shaped
contraction to assess the of the red blood cells (RBCs) deformability: (a) main dimensions; (b) flow
phenomena happening in this kind of geometry. Adapted with permission from [45].
The visualization and measurements of the motion of the RBCs were performed by means
of a high-speed video microscopy system that includes an inverted microscope (IX71, Olympus,
Tokyo, Japan) combined with a high-speed camera (Fastcam SA3, Photron, San Diego, CA, USA).
The microfluidic device was placed on the microscope stage and the flow rate of the working fluids
was kept constant at 3 µL/min. by using a syringe pump (PHD Ultra, Harvard Apparatus, Holliston,
MA, USA) with a 1 mL disposable syringe (Terumo) (Figure 2). For all of the flow measurements, the
average shear rate at the hyperbolic contraction region was about 1750 s−1. The average or pseudo
shear rate was calculated by γ = UDh , where U is the mean velocity of the blood cells that were obtained
at the contraction region, and Dh is the hydraulic diameter at the end of the contraction region.
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The images of the RBCs flowing through the hyperbolic contraction were captured by the
high-speed camera with a frame rate of 3000 frames/s and a shutter speed ratio of 1/75,000 s. These
parameters were selected in order to obtain well defined RBCs and avoid possible image distortions
that are caused by the high flow velocities at the contraction region. Table 1 shows the most of the
relevant experimental parameters that were used to perform the RBCs deformability measurements.
Table 1. Main experimental parameters used to perform the RBCs deformability measurements.
Main Experimental Parameters
Maximum width of the microchannel 400 µm
Minimum width of the microchannel 20 µm
Total length of the contraction region 382 µm
Depth of the microchannel 50 µm
Flow rate (syringe of 1 mL) 3 µL/min
Average shear rate 1750 s−1
Shear viscosity of the Dextran 40 4.5 × 10−3 Pa·s
Density of the Dextran 40 1046 kg/m3
Haematocrit of the working fluid 1%
Temperature of the working fluid 22 ◦C
Magnification (M) 40×
Numerical Aperture (NA) 0.75
Frame rate 3000 frames/s
Exposure time 1/75,000 s
2.3. Working Fluids
To perform the RBCs deformability studies, Dextran 40 (Sigma-Aldrich, Saint Louis, MO, USA)
at 10% (w/v) solution containing 1% of haematocrit (Hct 1%, v/v) of RBCs was used as the working
fluid. Briefly, venous blood samples from both patients and healthy donors were collected into
10 mL BD-Vacutainers (BD, Franklin Lakes, NJ, USA) tubes containing ethylenediaminetetraacetic
acid (EDTA) to prevent coagulation. The RBCs and buffy coat were separated from the plasma after
centrifugation (2500 rpm for 10 min., at 4 ◦C). The RBCs were then washed with physiological salt
solution (PSS) and then centrifuged, with this procedure repeated twice. The RBCs were suspended in
Dextran 40 to make several samples with low hematocrit levels of ~1% by volume (cf. Figure 3) to
obtain the measurements of individual RBC flowing through hyperbolic contraction. Dextran 40 was
used as substitute of the blood plasma, since it prevents not only the sedimentation of the RBCs during
the experimental assays, but also the cell clogging phenomenon. All of the analyses were performed
within a maximum period of 12 h, with blood samples being hermetically stored at 4 ◦C until being
used in the flow experiments.
Image analysis was essential to obtain sharper, brighter, and clearer images of the RBCs flowing
through the contraction, and to consequently obtain reliable velocity and deformability measurements,
at the regions of interest (ROI) in both contraction and expansion regions, where the RBCs deform
and recover to their normal circular shape, respectively (see Figure 3a and supplementary video).
The first step of this process involves the capture of videos with a resolution of 1024 × 576 pixels at
frame intervals of 330 µs at the end of the contraction region. Figure 4a shows a typical obtained image.
In order to reduce static artifacts in the images, a background image (Figure 4b) was created from
the original stack images, by averaging each pixel over the sequence of static images while using an
ImageJ function, called Z project, and then subtracted from the stack images. This process eliminates
all the static objects including the microchannel walls and some possible attached cells, which resulted
in having at the end, only the RBCs of interest (Figure 4c). Brightness/Contrast adjustment was also
applied to enhance the image quality. Finally, the greyscale images were converted to binary images
adjusting the threshold level (Figure 4d). At this stage, an Otsu threshold method was applied and
when required, the level was manually refined. This segmentation process generates objects of interest
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(RBCs) as black ellipsoidal objects against a white background. At the end, the flowing RBCs in the
binary images were measured frame by frame manually, by using Wand tool function in ImageJ. The
main output results of these measurements were the major and minor axis lengths of the RBCs and the
x-y coordinates of their centroid.
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Although different automatic methods to track RBCs in microfluidic devices have been reported in
the literature [45–49], further improvements still need to be achieved to perform reliable deformability
measurements. Hence, in the present study, hundreds of RBCs were manually tracked by using
the ImageJ plug-in, MTrackJ. By selecting this method, it is possible to easily track the cells by a
centroid based strategy and obtain their centroid position (x-y coordinates), by carefully tracking
individual RBCs and consequently determine their orientations and velocities within the hyperbolic
contraction and downstream of the contraction region. In this study, measurements were only
performed for the in focus cells flowing from the side, as it is possible to observe in the examples at the
supplementary video. In this video, it is also possible to observe a RBC that flows from the top (the
biconcave disc shape cell). However, the cells flowing with this orientation were not considered in our
deformability measurements.
2.4. Statistical Analysis
The statistical analysis was performed by using one-way ANOVA (Microsoft Office Excel, version
Office 365 ProPlus). Before performing the ANOVA analysis, the requirements regarding normal
distribution were tested by means of the Shapiro–Wilk’s test. In this test, the null hypothesis that
the population is normally distributed was accepted since p > 0.05. Overall, for the constriction
region, we have measured the deformability of 1769 RBCs corresponding to 12 ESKD patients and
a total of 736 measured RBCs, eight ESKDD patients and a total of 444 measured RBCs, and seven
healthy controls and a total of 589 measured RBCs. All of the statistical tests were performed at a 95%
confidence level; differences with p < 0.05 were considered to be statistically significant, and were
represented as asterisks (*).
3. Results and Discussion
The determination of the RBC velocities plays an essential role in confirming whether the cells
are deformed under similar flow conditions. Hence, before the deformability assessment of each
sample, velocity measurements were performed and compared. After analyzing the average velocities
of each sample at the contraction region, it was decided to compare the RBC deformability for all of
the samples having similar flow conditions, i.e., both shear and extensional flows. Figure 6 shows
representative RBC trajectories that were manually tracked within the hyperbolic contraction and
downstream of the contraction region.
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Figure 7 shows the measurements of the velocity and DR of representative RBCs flowing through
the hyperbolic-shaped contraction (ROI region) for both healthy donors and ESKD patients (see also
supplementary video). The majority of the RBC velocities tend to slightly increase as they move
through the exit of the contraction, and then they suffer a dramatic reduction of their velocities when
flowing from the narrow to the wide region of the microchannel (cf. Figure 7a). Overall, the velocities
of the RBCs of both control and ESKD patients present a similar qualitative flow behavior at the tested
region of the device, which results in a good agreement in the deformability results obtained in all the
samples (cf. Figure 7b). However, it should be noted that, quantitatively, the DR results indicate that
the deformability of the ESKD RBCs under extensional flow tend to be smaller when compared to the
control RBCs (cf. Figure 7b). These latter results are further confirmed with the measurements that
were performed with several ESKD patients and healthy individual, as shown in Figure 8. Additionally,
during all the flow visualization measurements at constriction region, the RBCs did not show any
tumbling and rolling motion, which was mainly due to the uniform and strong extensional flow
generated along the hyperbolic-shaped contraction. Note that, under shear flow, it is extremely
common to observe RBCs flowing with complex dynamics, such as tumbling and rolling [26,46]. In the
present study, the RBCs only exhibited such kind of complex flow motions at the expansion region,
due to the dominant shear flow with respect to the extensional flow (cf. supplementary video). Hence,
by using the proposed method, when the RBCs enter into the contraction region, they change from a
circular to an elliptical shape, with a tendency to become increasingly elongated as they moved through
the hyperbolic contraction. This latter flow behavior is possible to observe in Figure 7b. Additionally,
in this figure, it can be observed that, at the downstream of the contraction region, the cells start to
recover their nearly circular shape, exhibiting a DR that is close to one.
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Figure 8 shows the box plot of the deformation ratio (DR) for three different groups, i.e., samples
of ESKD patients without diabetes type II (n = 12), samples of ESKD patients with diabetes (n = 8)
type II, and samples from healthy donors (n = 7). For each patient sample, more than 60 RBCs with
similar flow behavior were individually measured and analyzed at the hyperbolic constriction and
recovering channel of the proposed microfluidic device (Figure 8). Additionally, Table 2 shows the data
of the average DR and standard deviation (SD) of the RBCs deformation at both the contraction and
expansion region for all of the tested samples. Overall, the deformability of ESKD patients (with and
without diabetes) measured at the hyperbolic constriction is lower in comparison with the RBCs from
the normal healthy controls (p < 0.05), as shown in Figure 8b. This difference is more evident when
only the group of ESKD patients with diabetes is taken into consideration. For instance, RBCs from
ESKD patients without diabetes elongates, on average, 8% less within the hyperbolic contraction when
compared to healthy controls, whereas RBCs from ESKD patients with diabetes elongates on average
14% less than the healthy controls (cf. Figure 8b). On the other hand, all of the cells analyzed, both
healthy and diseased, have been shown to have a similar DR (nearly to 1, i.e., close to a spherical-shape)
at the expansion region of the microchannel (Figure 8c,d), where cells tend to recover to their normal
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circular shape due to the low shear rate and a negligible strain rate. Therefore, the results from the
present study demonstrate that the RBCs DR measured by using the proposed microfluidic device
can be considered as a sensitive mechanical biomarker, as it was able to detect changes in DR of
the RBCs from patients with different diseases in comparison with healthy ones. Moreover, this
study also corroborates other previous research works [13,14], where, by using different deformability
measurement techniques, it was shown that elongation of RBCs from patients with diabetes is lower in
comparison with the non-diabetic healthy controls.
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Figure 8. Box plot representation of RBC’s deformation ratio (DR) measured by the proposed
microfluidic device: (a) DR of individual donors, including ESKD patients, ESKD patients with diabetes
and healthy donors (control) in the hyperbolic constriction, (b) Average DR of the groups of donors,
including ESKD patients, ESKD patients with diabetes and healthy donors (control) in the hyperbolic
constriction, (c) DR of individual donors, including ESKD patients, ESKD patients with diabetes and
healthy donors (control) at the expansion region, (d) Average DR of the groups of donors, including
ESKD patients, ESKD patients with diabetes and healthy donors (control at the expansion region.
The asterisks (*) indicates statistically significant differences (p < 0.05) determined by Student’s t test.
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Table 2. Average DR and standard deviation (SD) of the flowing RBCs at both contraction and expansion
region for each sample.
Blood Samples
Contraction Region DR Expansion Region DR
Average SD Average SD
ESKD1 3.03 0.34 1.12 0.08
ESKD2 2.79 0.36 1.10 0.09
ESKD3 2.86 0.26 1.13 0.06
ESKD4 3.11 0.25 1.14 0.08
ESKD5 3.03 0.39 1.12 0.06
ESKD6 3.15 0.37 1.15 0.07
ESKD7 2.89 0.31 1.15 0.08
ESKD8 2.93 0.26 1.16 0.05
ESKD9 2.94 0.35 1.13 0.10
ESKD10 3.02 0.24 1.10 0.05
ESKD11 2.96 0.32 1.14 0.06
ESKD12 3.17 0.35 1.13 0.08
ESKDD1 2.78 0.25 1.12 0.05
ESKDD2 2.60 0.27 1.13 0.07
ESKDD3 3.01 0.32 1.15 0.05
ESKDD4 3.02 0.32 1.13 0.08
ESKDD5 2.72 0.37 1.14 0.07
ESKDD6 2.74 0.28 1.16 0.08
ESKDD7 2.69 0.34 1.14 0.08
ESKDD8 2.81 0.43 1.11 0.06
C1 2.99 0.21 1.14 0.07
C2 3.12 0.23 1.13 0.06
C3 3.28 0.22 1.13 0.10
C4 3.23 0.27 1.12 0.06
C5 3.24 0.31 1.15 0.07
C6 3.07 0.30 1.14 0.07
C7 3.27 0.27 1.15 0.06
As previously mentioned, RBCs occupy almost half of the total blood volume and, under healthy
conditions, they are highly deformable in order to pass through capillaries with dimensions several
times lower than the RBCs size [16]. Hence, it is well known that the RBC deformability plays a crucial
role in the rheological properties of blood in microvessels, i.e., the decrease of the RBC deformability
might result in an increase of the blood viscosity and, consequently, in an increased tendency for
microvascular complications and associated diseases. The results that are presented in this study
indicate that the ESKD patients with and without diabetes have a tendency to decrease the RBCs
deformability and, as a result, night have a substantial impact in the whole blood viscosity of these
patient’s health. This can result in an elicit hemolysis in the capillaries and premature sequestration
of RBCs by the reticulo-endothelial system, and altering tissue oxygenation. However, a larger scale
study is required to confirm whether the decrease of the RBC deformability contributes to the increase
of the blood viscosity, or not.
4. Limitations and Future Directions
The primary goal of the present work was to investigate the ability of hyperbolic converging
microchannels to be used as an alternative clinical tool that is suitable to detect and diagnose RBC
related diseases. To accomplish it, high speed microfluidic studies were performed in a hyperbolic
contraction microchannel with a uniform depth of about 50 µm. The selection of this depth was
a compromise solution mainly due to the limitation of our high-speed video camera: although,
by decreasing the microchannel depth, the orientation of the cells tend to be more stable, the difficulty
to measure the RBCs deformability increases due to the extremely high velocities that were generated at
this region. The major advantage of this geometrical modification is the ability to use simple automatic
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methods, which results in a significant increase of the number of cell measurements performed under
similar flow conditions. Nevertheless, in this study, we opted for manual measurements to guarantee
that only adequate cells were included.
Additionally, we would like to refer that recently, Schonbrun et al. [50] have shown that by
using blue light the hemoglobin absorption makes cells extremely visible and easier to track in
microchannels for low shear rates. Although this optical option looks promising, further research
needs to be performed regarding the ability to measure blood cells at high shear rates. We consider that
a combination of both strategies could result in a promising methodology to preform DR measurement
of RBCs with high accuracy. The high-speed camera used due to its cost can be a limitation to consider
the technique as a common tool; however, during the last two decades, the cost of this technology
has been decreasing in an exponential way, thus we believe that it will be possible to have in a more
affordable way a high-speed system in the future. Another way can be the use of compact CCD cameras
due its capacity to achieve similar sensitivity and exposure, but in an affordable way.
5. Conclusions
RBCs deformability plays a crucial role in microcirculation and the loss of their deformability can
be related to many pathologies. The present study investigated the ability of hyperbolic microfluidic
channels to measure the deformation and RBC motion from the blood samples of patients with ESKD
(with and without diabetes type II) compared to healthy individuals (used as control) and exploit the
relevance of this method to be used as viable clinical tool suitable to detect and diagnose RBC related
disease. This study has shown the potential of the proposed device to detect changes in DR of the RBCs
from patients with different complications. Overall, the elongation of RBCs from the ESKD patients,
with and without diabetes, was lower in comparison with the RBCs from the healthy controls, being
the difference more evident for the group of ESKD patients with diabetes. Another important finding
was related to the comparison of the cells at the expansion region, where the RBCs have recovered their
normal circular shape. At this region, the cells were deformed under low shear rate and negligible
strain rate. Under those conditions, we have not found any difference between the ESKD patients and
the healthy controls. This latter result indicates that the RBCs need to be submitted to high mechanical
stresses to deform the cells and, consequently, to detect different state of blood diseases.
Additionally, the results that are presented in this study indicate that the ESKD patients with and
without diabetes have a tendency to decrease the RBCs deformability, which might have a substantial
impact in the whole blood viscosity of these patients. However, a larger scale study would be necessary
to confirm whether the decrease of the RBC deformability contributes to the increase of the blood
viscosity, or not. Although the proposed microfluidic tool requires further improvements, the results
that were obtained from the present study suggest that this technique is able to assure a simple and
efficient cell deformability assessment at both physiological and pathological situations.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-666X/10/10/645/s1,
Figure S1: Images from a video where it is possible to observe that the RBCs rotation only happens at the expansion
region of the microchannel, and Video S1: Visualization of RBCs flowing within the hyperbolic contraction and
downstream of the contraction region.
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